Visp, May 9th 2019 – Swissfillon AG ,an agile fill & finish contract manufacturing organization (CMO) for complex pharmaceutical and biopharmaceutical products, announces todaysuccessful facility inspection of its GMP manufacturing site, located in Visp. The Swissfillon production site in Visp was assessed by the USFDA (US Food and Drug Administration) between April 15 and 24, 2019.
Swissfillon AG in Visp has faced the scrutiny of the FDA – Food and Drug Administration – between April 15 and 24, 2019. After intensive seven days in which the Swissfillon AG team faced the questions and challenges of the inspectors, the following emerged: The FDA inspectors have given their okay, so that Swissfillon AG
Between 15 and 19 April 2019, Swissfillon AG in Visp will face the scrutiny of the FDA – Food and Drug Administration. The inspection authority is the Food and Drug Administration of the USA. It has set itself the task of protecting public health in the United States and, in this context, monitors the safety
Pharmaceutical companies that want to complete their products with the highest
quality and safety in the filling process are in good hands with Swissfillon. We fill vials, capsules and disposable syringes under sterile conditions and in outstanding quality. You can concentrate yourselves on your pharmaceutical products, which we fill precisely and reliably. That is our passion.